Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Total article views   HTML views PDF downloads Totals
14,563 Dovepress* 13,190+ 2,275 15,465
PubMed Central* 1,373 672 2,045
Totals 14,563 2,947 17,510
*Since 14 September 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar